Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

KRYSKrystal Biotech, Inc.

Nasdaq · CIK 0001711279
Filer categoryLarge accelerated filer
Entity typeoperating
SIC2836 Biological Products, (No Diagnostic Substances)
FY end1231
XBRL facts309

Identity from submissions API

NameKrystal Biotech, Inc.
CIK0001711279
TickersKRYS
ExchangesNasdaq
Entity typeoperating
CategoryLarge accelerated filer
SIC2836 Biological Products, (No Diagnostic Substances)
EIN821080209
LEI—
Fiscal year end1231
State of incorporation—
Phone(412) 586-5830
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
2100 WHARTON STREET
SUITE 701
PITTSBURGH
PA
15203
PA
Mailing address
2100 WHARTON STREET
SUITE 701
PITTSBURGH
PA
15203
PA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

514 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-13 4 FORM 4 0001209059-26-000011 4764
2026-11-02 8-K 8-K 2.02,9.01 0001711279-26-000072 001-38210 261509875 34 591150 1 1
2026-11-02 10-Q 10-Q 0001711279-26-000071 001-38210 261509871 34 6552546 1 1
2026-10-30 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002100121-26-001077 005-90133 261507003 34 7464
2026-10-27 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0002012383-26-003918 005-90133 261491765 34 11101
2026-10-15 8-K 8-K 7.01,9.01 0001711279-26-000064 001-38210 261461320 34 609071 1 1
2026-09-16 4 FORM 4 0001209059-26-000008 8035
2026-09-16 4 FORM 4 0001852880-26-000002 8066
2026-09-16 4 FORM 4 0001967722-26-000002 8103
2026-09-16 4 FORM 4 0001836440-26-000002 8100
2026-09-16 4 FORM 4 0001711279-26-000060 8027
2026-09-16 4 FORM 4 0001532023-26-000002 8052
2026-09-04 4 FORM 4 0001298711-26-000009 30928
2026-09-04 4 FORM 4 0001298709-26-000011 30931
2026-09-04 144 xsl144X01/primary_doc.xml 0001950047-26-009149 001-38210 261362506 33 4880
2026-09-04 144 xsl144X01/primary_doc.xml 0001950047-26-009148 001-38210 261362501 33 4885
2026-08-14 4 FORM 4 0001209059-26-000006 18947
2026-08-14 144 xsl144X01/primary_doc.xml 0001958244-26-000513 001-38210 261283769 33 4976
2026-08-03 8-K 8-K 2.02,9.01 0001711279-26-000058 001-38210 261230436 34 587551 1 1
2026-08-03 10-Q 10-Q 0001711279-26-000057 001-38210 261230435 34 6247097 1 1
2026-07-21 8-K 8-K 8.01,9.01 0001711279-26-000050 001-38210 261191148 34 222109 1 1
2026-06-26 4 FORM 4 0002114900-26-000009 8578
2026-06-25 144 xsl144X01/primary_doc.xml 0001959173-26-004871 001-38210 261118359 33 5000
2026-06-05 4 FORM 4 0001298711-26-000006 25945
2026-06-05 4 FORM 4 0001298709-26-000009 25465
2026-06-04 144 xsl144X01/primary_doc.xml 0001950047-26-005653 001-38210 261065468 33 4880
2026-06-04 144 xsl144X01/primary_doc.xml 0001950047-26-005652 001-38210 261065461 33 4885
2026-05-27 4 FORM 4 0002114900-26-000006 5126
2026-05-26 144 xsl144X01/primary_doc.xml 0001959173-26-003960 001-38210 261016608 33 4424
2026-05-20 8-K 8-K 5.07 0001711279-26-000047 001-38210 261001013 34 145909 1 1
2026-05-04 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001298709-26-000007 005-90133 26934595 34 176895
2026-05-04 8-K 8-K 9.01 0001711279-26-000044 001-38210 26934591 34 234378 1 1
2026-05-04 10-Q 10-Q 0001711279-26-000043 001-38210 26934589 34 9419781 1 1
2026-04-29 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0002100121-26-000495 005-90133 26914026 34 7337
2026-04-03 ARS ARS 0001711279-26-000038 001-38210 26838603 34 48776132
2026-04-03 DEFA14A DEFA14A 0001711279-26-000037 001-38210 26838590 34 1167099
2026-04-03 DEF 14A DEF 14A 0001711279-26-000036 001-38210 26838575 34 3827319 1 1
2026-03-27 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000102909-26-001667 005-90133 26801890 34 7158
2026-03-06 3 FORM 3 0002114613-26-000003 279779
2026-03-06 3 FORM 3 0002114900-26-000003 319876
2026-03-06 4 FORM 4 0001298711-26-000004 24280
2026-03-06 4 FORM 4 0001298709-26-000004 24298
2026-03-04 144 xsl144X01/primary_doc.xml 0001950047-26-002188 001-38210 26722145 33 4879
2026-03-04 144 xsl144X01/primary_doc.xml 0001950047-26-002184 001-38210 26722106 33 4884
2026-03-03 4 FORM 4 0001801385-26-000002 21193
2026-03-03 4 FORM 4 0001298711-26-000002 36104
2026-03-03 4 FORM 4 0001298709-26-000002 34865
2026-03-03 4 FORM 4 0001711279-26-000023 8173
2026-03-02 144 xsl144X01/primary_doc.xml 0001959173-26-001640 001-38210 26705824 33 5173
2026-02-27 144 xsl144X01/primary_doc.xml 0001628280-26-012879 001-38210 26700954 33 6919
2026-02-26 4 FORM 4 0001711279-26-000021 47138
2026-02-26 144 xsl144X01/primary_doc.xml 0001628280-26-012361 001-38210 26689674 33 6282
2026-02-25 144 xsl144X01/primary_doc.xml 0001628280-26-011735 001-38210 26679494 33 5647
2026-02-24 144 xsl144X01/primary_doc.xml 0001959173-26-001452 001-38210 26673021 33 4991
2026-02-24 144 xsl144X01/primary_doc.xml 0001628280-26-011149 001-38210 26672358 33 5019
2026-02-23 4 FORM 4 0001209059-26-000003 9459
2026-02-19 144 xsl144X01/primary_doc.xml 0001959173-26-001208 001-38210 26652946 33 4279
2026-02-17 8-K 8-K 2.02 0001711279-26-000018 001-38210 26636344 34 277014 1 1
2026-02-17 10-K 10-K 0001711279-26-000016 001-38210 26636335 34 10298174 1 1
2026-02-11 4 FORM 4 0001711279-26-000011 21350
2026-02-09 144 xsl144X01/primary_doc.xml 0001959173-26-000774 001-38210 26611427 33 4530
2026-01-12 8-K 8-K 2.02,7.01,9.01 0001711279-26-000008 001-38210 26524693 34 171673 1 1
2026-01-08 8-K 8-K 7.01,9.01 0001711279-26-000005 001-38210 26520061 34 4885323 1 1
2025-12-23 8-K 8-K 5.02,9.01 0001711279-25-000092 001-38210 251601393 34 138847 1 1
2025-12-05 4 FORM 4 0001298711-25-000013 38745
2025-12-05 4 FORM 4 0001298709-25-000013 38601
2025-12-04 144 xsl144X01/primary_doc.xml 0001950047-25-009792 001-38210 251550283 33 4885
2025-12-04 144 xsl144X01/primary_doc.xml 0001950047-25-009786 001-38210 251550263 33 4880
2025-11-03 8-K 8-K 2.02 0001711279-25-000088 001-38210 251442080 34 281731 1 1
2025-11-03 10-Q 10-Q 0001711279-25-000087 001-38210 251442077 34 6435642 1 1
2025-10-22 8-K 8-K 8.01 0001711279-25-000082 001-38210 251408634 34 136380 1 1
2025-08-04 8-K 8-K 2.02,9.01 0001711279-25-000078 001-38210 251177970 34 281164 1 1
2025-08-04 10-Q 10-Q 0001711279-25-000077 001-38210 251177961 34 6334618 1 1
2025-07-25 8-K 8-K 7.01 0001711279-25-000071 001-38210 251149014 34 160159 1 1
2025-07-24 8-K 8-K 7.01 0001711279-25-000069 001-38210 251147598 34 3595106 1 1
2025-07-16 4 FORM 4 0001298711-25-000009 21162
2025-07-16 4 FORM 4 0001298709-25-000009 21339
2025-07-11 4 FORM 4 0001298711-25-000007 15813
2025-07-11 4 FORM 4 0001298709-25-000007 15828
2025-07-09 144 xsl144X01/primary_doc.xml 0001950047-25-004936 001-38210 251113811 33 4880
2025-07-09 144 xsl144X01/primary_doc.xml 0001950047-25-004935 001-38210 251113804 33 4885
2025-07-09 8-K 8-K 7.01 0001711279-25-000065 001-38210 251112388 34 2845766 1 1
2025-06-30 4 FORM 4 0001532023-25-000005 5251
2025-06-30 4 FORM 4 0001852880-25-000003 5265
2025-06-30 4 FORM 4 0001711279-25-000057 5226
2025-06-30 4 FORM 4 0001836440-25-000003 5299
2025-06-30 4 FORM 4 0001209059-25-000003 5234
2025-06-30 4 FORM 4 0001967722-25-000002 5302
2025-06-02 8-K 8-K 8.01 0001711279-25-000055 001-38210 251016065 34 569671 1 1
2025-05-19 8-K 8-K 5.07 0001711279-25-000051 001-38210 25964965 34 149855 1 1
2025-05-13 8-K 8-K 7.01 0001711279-25-000048 001-38210 25936512 34 672612 1 1
2025-05-06 8-K 8-K 2.02,9.01 0001711279-25-000045 001-38210 25915332 34 255072 1 1
2025-05-06 10-Q 10-Q 0001711279-25-000044 001-38210 25915330 34 6256338 1 1
2025-05-06 8-K 8-K 7.01 0001711279-25-000037 001-38210 25914610 34 638769 1 1
2025-04-28 8-K 8-K 7.01 0001711279-25-000029 001-38210 25876269 34 168015 1 1
2025-04-03 ARS ARS 0001711279-25-000025 001-38210 25810293 34 49566688
2025-04-03 DEFA14A DEFA14A 0001711279-25-000022 001-38210 25810196 34 156914
2025-04-03 DEF 14A DEF 14A 0001711279-25-000021 001-38210 25810183 34 3788132 1 1
2025-03-13 4 FORM 4 0001298711-25-000004 25217
2025-03-13 4 FORM 4 0001298709-25-000004 25274
2025-03-13 144 xsl144X01/primary_doc.xml 0001950047-25-001824 001-38210 25736195 33 4887
2025-03-13 144 xsl144X01/primary_doc.xml 0001950047-25-001823 001-38210 25736183 33 4894
2025-02-28 4 FORM 4 0001801385-25-000002 23993
2025-02-28 4 FORM 4 0001298711-25-000002 38526
2025-02-28 4 FORM 4 0001298709-25-000002 40080
2025-02-28 8-K 8-K 9.01 0001711279-25-000013 001-38210 25691586 34 174669 1 1
2025-02-27 144 xsl144X01/primary_doc.xml 0001959173-25-001418 001-38210 25675596 33 4544
2025-02-19 8-K 8-K 7.01,9.01 0001711279-25-000009 001-38210 25637179 34 281145 1 1
2025-02-19 10-K 10-K 0001711279-25-000008 001-38210 25637174 34 18574595 1 1
2025-02-05 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000093751-25-000090 005-90133 25590933 34 8014
2024-12-18 8-K 8-K 7.01,9.01 0001711279-24-000065 001-38210 241557770 34 170896 1 1
2024-12-13 4 FORM 4 0001298711-24-000015 37641
2024-12-13 4 FORM 4 0001298709-24-000017 38305
2024-12-13 144 xsl144X01/primary_doc.xml 0001950047-24-009786 001-38210 241548666 33 4897
2024-12-13 144 xsl144X01/primary_doc.xml 0001950047-24-009785 001-38210 241548661 33 4888
2024-12-12 8-K 8-K 7.01,9.01 0001711279-24-000062 001-38210 241543323 34 4036068 1 1
2024-11-14 SC 13G/A SC 13G/A 0001104659-24-119428 005-90133 241465546 34 72810
2024-11-12 SC 13G/A filing.txt 0000315066-24-002785 005-90133 241444876 34 8254
2024-11-04 10-Q 10-Q 0001711279-24-000056 001-38210 241420804 34 6401968 1 1
2024-11-04 8-K 8-K 2.02,9.01 0001711279-24-000055 001-38210 241420802 34 284600 1 1
2024-10-16 SC 13G Krystal_Biotech_Inc.htm 0000093751-24-000758 005-90133 241373955 34 55975
2024-09-13 4 FORM 4 0001298711-24-000013 35606
2024-09-13 4 FORM 4 0001298709-24-000014 35439
2024-09-13 4 FORM 4 0001209059-24-000004 4634
2024-09-12 144 xsl144X01/primary_doc.xml 0001950047-24-007009 001-38210 241295392 33 4888
2024-09-12 144 xsl144X01/primary_doc.xml 0001950047-24-007008 001-38210 241295388 33 4893
2024-08-28 8-K 8-K 7.01,9.01 0001711279-24-000045 001-38210 241255957 34 5974905 1 1
2024-08-05 10-Q 10-Q 0001711279-24-000040 001-38210 241173169 34 6610790 1 1
2024-08-05 8-K 8-K 2.02,9.01 0001711279-24-000038 001-38210 241173156 34 279550 1 1
2024-07-10 SC 13G/A SCHEDULE 13G/A 0001104659-24-078880 005-90133 241109475 34 13011
2024-07-08 SC 13G/A us5011471027_070824.txt 0001086364-24-008144 005-90133 241105147 34 13907
2024-07-01 4 FORM 4 0001532023-24-000010 5258
2024-07-01 4 FORM 4 0001711279-24-000029 5233
2024-07-01 4 FORM 4 0001836440-24-000004 5306
2024-07-01 4 FORM 4 0001967722-24-000003 5309
2024-07-01 4 FORM 4 0001852880-24-000002 5272
2024-07-01 4 FORM 4 0001209059-24-000002 5241
2024-06-11 4 FORM 4 0001298711-24-000011 37090
2024-06-11 4 FORM 4 0001298709-24-000011 37106
2024-06-11 144 xsl144X01/primary_doc.xml 0001950047-24-004609 001-38210 241036118 33 4891
2024-06-11 144 xsl144X01/primary_doc.xml 0001950047-24-004608 001-38210 241036113 33 4886
2024-05-22 4 FORM 4 0001532023-24-000008 12107
2024-05-21 8-K 8-K 5.07 0001711279-24-000027 001-38210 24970031 34 211881 1 1
2024-05-20 144 xsl144X01/primary_doc.xml 0001959173-24-003742 001-38210 24965361 33 4310
2024-05-08 8-K 8-K 7.01,9.01 0001711279-24-000023 001-38210 24923745 34 520813 1 1
2024-05-06 10-Q 10-Q 0001711279-24-000020 001-38210 24915731 34 5664021 1 1
2024-05-06 8-K 8-K 2.02,9.01 0001711279-24-000018 001-38210 24915639 34 497024 1 1
2024-04-04 DEFA14A DEFA14A 0001711279-24-000014 001-38210 24823231 34 1141642
2024-04-04 DEF 14A DEF 14A 0001711279-24-000013 001-38210 24823210 34 3845061 1 1
2024-03-11 4 FORM 4 0001298711-24-000009 33506
2024-03-11 4 FORM 4 0001298709-24-000009 33521
2024-03-11 144 xsl144X01/primary_doc.xml 0001950047-24-002167 001-38210 24738632 33 4885
2024-03-11 144 xsl144X01/primary_doc.xml 0001950047-24-002166 001-38210 24738627 33 4890
2024-03-01 4 FORM 4 0001801385-24-000011 41340
2024-03-01 4 FORM 4 0001801385-24-000009 56625
2024-03-01 4 FORM 4 0001298711-24-000006 18911
2024-03-01 4 FORM 4 0001298709-24-000006 21594
2024-02-28 4 FORM 4 0001298711-24-000004 7412
2024-02-28 4 FORM 4 0001298709-24-000004 7434
2024-02-28 4 FORM 4 0001801385-24-000007 19941
2024-02-28 144 xsl144X01/primary_doc.xml 0001959173-24-001533 001-38210 24695932 33 5805
2024-02-26 144 xsl144X01/primary_doc.xml 0001959173-24-001374 001-38210 24676354 33 5175
2024-02-26 8-K 8-K 2.02,9.01 0001711279-24-000009 001-38210 24673609 34 557783 1 1
2024-02-26 S-8 S-8 0001711279-24-000007 333-277341 24673588 33 79196
2024-02-26 10-K 10-K 0001711279-24-000005 001-38210 24673576 34 8451654 1 1
2024-02-14 SC 13G/A SC 13G/A 0001104659-24-023772 005-90133 24638930 34 77398
2024-02-14 SC 13G/A KRYSTAL BIOTECH, INC. 0000902664-24-001618 005-90133 24633072 34 59629
2024-02-13 SC 13G SCHEDULE 13G 0001104659-24-021308 005-90133 24628774 34 13010
2024-02-12 SC 13G/A filing.txt 0000315066-24-001629 005-90133 24618424 34 8251
2024-02-09 SC 13G/A filing.txt 0000315066-24-001244 005-90133 24611763 34 8250
2024-01-29 SC 13G/A us5011471027_012924.txt 0001086364-24-005078 005-90133 24573112 34 13648
2024-01-24 4 FORM 4 0001801385-24-000002 8769
2024-01-22 144 xsl144X01/primary_doc.xml 0001959173-24-000380 001-38210 24547586 33 4445
2023-12-12 4 FORM 4 0001298711-23-000020 20583
2023-12-12 4 FORM 4 0001298709-23-000023 20601
2023-12-11 144 xsl144X01/primary_doc.xml 0001950047-23-005859 001-38210 231478414 33 4656
2023-12-11 144 xsl144X01/primary_doc.xml 0001950047-23-005857 001-38210 231478404 33 4662
2023-11-06 8-K 8-K 2.02,9.01 0001711279-23-000074 001-38210 231378094 34 528715 1 1
2023-11-06 10-Q 10-Q 0001711279-23-000073 001-38210 231378091 34 6524392 1 1
2023-10-02 144 xsl144X01/primary_doc.xml 0001959173-23-004131 001-38210 231298542 33 7897
2023-09-12 4 FORM 4 0001298711-23-000017 23331
2023-09-12 4 FORM 4 0001298709-23-000020 23311
2023-09-11 144 xsl144X01/primary_doc.xml 0001950047-23-003896 001-38210 231247951 33 4661
2023-09-11 144 xsl144X01/primary_doc.xml 0001950047-23-003895 001-38210 231247947 33 4656
2023-08-21 144 xsl144X01/primary_doc.xml 0001959173-23-003429 001-38210 231190207 33 7402
2023-08-16 144 xsl144X01/primary_doc.xml 0001959173-23-003314 001-38210 231178858 33 6785
2023-08-15 144 xsl144X01/primary_doc.xml 0001959173-23-003272 001-38210 231175580 33 6139
2023-08-11 144 xsl144X01/primary_doc.xml 0001959173-23-003167 001-38210 231164741 33 5509
2023-08-10 144 xsl144X01/primary_doc.xml 0001959173-23-003126 001-38210 231160968 33 4860
2023-08-07 8-K 8-K 5.02 0001711279-23-000069 001-38210 231145736 34 149093 1 1
2023-08-07 8-K 8-K 2.02,9.01 0001711279-23-000067 001-38210 231145568 34 502810 1 1
2023-08-07 10-Q 10-Q 0001711279-23-000064 001-38210 231145564 34 5971475 1 1
2023-07-26 8-K 8-K 7.01,9.01 0001711279-23-000061 001-38210 231113423 34 5436657 1 1
2023-07-18 S-3ASR S-3ASR 0001193125-23-188846 333-273303 231094299 33 354727
2023-07-03 4 FORM 4 0001711279-23-000059 5227
2023-07-03 4 FORM 4 0001711279-23-000057 5190
2023-07-03 4 FORM 4 0001711279-23-000055 5159
2023-07-03 4 FORM 4 0001711279-23-000053 5224
2023-07-03 4 FORM 4 0001711279-23-000051 5151
2023-07-03 4 FORM 4 0001711279-23-000049 5176
2023-06-09 4 FORM 4 0001711279-23-000046 20409
2023-06-09 4 FORM 4 0001860010-23-000004 12758
2023-06-09 144 xsl144X01/primary_doc.xml 0001950047-23-001449 001-38210 231005505 33 4664
2023-06-08 144 xsl144X01/primary_doc.xml 0001971857-23-000232 001-38210 231002500 33 6114
2023-06-02 4 FORM 4 0001298711-23-000015 16178
2023-06-02 4 FORM 4 0001298709-23-000018 16198
2023-05-31 144 xsl144X01/primary_doc.xml 0001950047-23-001078 001-38210 23981394 33 6190
2023-05-31 144 xsl144X01/primary_doc.xml 0001950047-23-001077 001-38210 23981302 33 6185
2023-05-23 8-K 8-K 5.07 0001711279-23-000044 001-38210 23949236 34 177095 1 1
2023-05-23 4 FORM 4 0001801385-23-000004 40372
2023-05-23 4 FORM 4 0001711279-23-000042 5924
2023-05-22 144 xsl144X01/primary_doc.xml 0001950047-23-000841 001-38210 23945046 33 5425
2023-05-22 8-K 8-K 1.01,3.02,7.01,9.01 0001711279-23-000039 001-38210 23942442 34 687170 1 1
2023-05-19 8-K 8-K 7.01,8.01,9.01 0001711279-23-000037 001-38210 23941377 34 423800 1 1
2023-05-19 144 xsl144X01/primary_doc.xml 0001950047-23-000803 001-38210 23940533 33 5280
2023-05-19 144 xsl144X01/primary_doc.xml 0001971857-23-000141 001-38210 23940347 33 5505
2023-05-11 4 FORM 4 0001711279-23-000035 5924
2023-05-11 8-K 8-K 7.01,9.01 0001711279-23-000033 001-38210 23908850 34 658456 1 1
2023-05-10 SC 13G/A filing.txt 0000315066-23-002261 005-90133 23904690 34 8212
2023-05-08 8-K 8-K 1.01,9.01 0001193125-23-137744 001-38210 23896066 34 389594 1 1
2023-05-08 424B5 424B5 0001193125-23-137738 333-271167 23896059 33 480515
2023-05-08 8-K 8-K 2.02,9.01 0001711279-23-000031 001-38210 23895956 34 481317 1 1
2023-05-08 10-Q 10-Q 0001711279-23-000029 001-38210 23895953 34 5691172 1 1
2023-04-24 UPLOAD filename1.pdf 0000000000-23-004057 39678
2023-04-24 8-K 8-K 7.01,9.01 0001711279-23-000025 001-38210 23837914 34 633960 1 1
2023-04-21 4 FORM 4 0001711279-23-000023 5923
2023-04-19 144 xsl144X01/primary_doc.xml 0001971857-23-000009 001-38210 23830259 33 4328
2023-04-18 4 FORM 4 0001298711-23-000012 23449
2023-04-18 4 FORM 4 0001298709-23-000015 23468
2023-04-17 144 xsl144X01/primary_doc.xml 0001950047-23-000152 001-38210 23824514 33 5388
2023-04-17 144 xsl144X01/primary_doc.xml 0001950047-23-000151 001-38210 23824504 33 5382
2023-04-11 CORRESP filename1.htm 0001711279-23-000021 26408
2023-04-06 S-3ASR S-3ASR 0001628280-23-011035 333-271167 23806767 33 577742
2023-04-04 4 FORM 4 0001967722-23-000007 5316
2023-04-04 DEFA14A DEFA14A 0001711279-23-000019 001-38210 23797959 34 1139738
2023-04-04 DEF 14A DEF 14A 0001711279-23-000018 001-38210 23797924 34 3561338 1 1
2023-03-30 UPLOAD filename1.pdf 0000000000-23-003196 43129
2023-03-09 3 FORM 3 0001967722-23-000005 322142
2023-03-06 8-K 8-K 5.02,9.01 0001711279-23-000014 001-38210 23709372 34 179552 1 1
2023-03-02 4 FORM 4 0001711279-23-000012 4756
2023-02-28 4 FORM 4 0001860010-23-000002 8954
2023-02-28 4 FORM 4 0001801385-23-000002 10120
2023-02-28 4 FORM 4 0001298711-23-000010 12641
2023-02-28 4 FORM 4 0001298709-23-000013 12667
2023-02-27 8-K 8-K 2.02,9.01 0001711279-23-000010 001-38210 23670041 34 504181 1 1
2023-02-27 10-K 10-K 0001711279-23-000008 001-38210 23670033 34 7731250 1 1
2023-02-14 SC 13G/A SC 13G/A 0001104659-23-021697 005-90133 23630039 34 79952
2023-02-14 SC 13G/A SCHEDULE 13G/A, AMENDMENT #2 0000899140-23-000365 005-90133 23628544 34 50683
2023-02-14 SC 13G KRYSTAL BIOTECH, INC. 0000902664-23-001672 005-90133 23623470 34 62690
2023-02-09 SC 13G/A filing.txt 0000315066-23-001801 005-90133 23603045 34 8117
2023-02-02 S-8 S-8 0001711279-23-000005 333-269539 23582015 33 94427
2023-02-01 SC 13G/A us5011471027_013123.txt 0001306550-23-005855 005-90133 23573866 34 13393
2023-01-19 4 FORM 4 0001298711-23-000006 23285
2023-01-19 4 FORM 4 0001298709-23-000006 23304
2023-01-09 8-K 8-K 7.01,9.01 0001711279-23-000003 001-38210 23516808 34 930688 1 1
2023-01-05 4 FORM 4 0001298711-23-000004 9197
2023-01-05 4 FORM 4 0001298709-23-000004 9216
2023-01-03 4 FORM 4 0001298711-23-000002 17518
2023-01-03 4 FORM 4 0001298709-23-000002 17537
2022-12-20 4 FORM 4 0001298711-22-000012 9199
2022-12-20 4 FORM 4 0001298709-22-000012 9218
2022-11-28 4 FORM 4 0001298711-22-000009 7532
2022-11-28 4 FORM 4 0001298709-22-000009 7278
2022-11-17 8-K 8-K 7.01,9.01 0001711279-22-000064 001-38210 221396892 34 4782226 1 1
2022-11-10 4 FORM 4 0001298711-22-000007 9193
2022-11-10 4 FORM 4 0001298709-22-000007 9186
2022-11-07 8-K 8-K 2.02,9.01 0001711279-22-000061 001-38210 221365619 34 257113 1 1
2022-11-07 10-Q 10-Q 0001711279-22-000058 001-38210 221363700 34 6200151 1 1
2022-11-03 8-K 8-K 7.01,9.01 0001711279-22-000055 001-38210 221358825 34 2202277 1 1
2022-08-18 8-K 8-K 7.01,8.01,9.01 0001711279-22-000052 001-38210 221178068 34 910848 1 1
2022-08-09 4 FORM 4 0001298711-22-000005 17522
2022-08-09 4 FORM 4 0001298709-22-000005 17515
2022-08-08 8-K 8-K 2.02,9.01 0001711279-22-000050 001-38210 221144851 34 485328 1 1
2022-08-08 10-Q 10-Q 0001711279-22-000047 001-38210 221142594 34 6031224 1 1
2022-07-01 4 FORM 4 0001711279-22-000042 5238
2022-07-01 4 FORM 4 0001711279-22-000040 5112
2022-07-01 4 FORM 4 0001711279-22-000038 5203
2022-07-01 4 FORM 4 0001711279-22-000036 5276
2022-07-01 4 FORM 4 0001711279-22-000034 5221
2022-06-22 8-K 8-K 7.01,9.01 0001711279-22-000032 001-38210 221030064 34 187651 1 1
2022-05-26 8-K 8-K 4.01,9.01 0001711279-22-000028 001-38210 22970684 34 176307 1 1
2022-05-23 8-K 8-K 5.07 0001711279-22-000024 001-38210 22951840 34 180828 1 1
2022-05-20 8-K 8-K 7.01,9.01 0001711279-22-000020 001-38210 22945336 34 1882320 1 1
2022-05-09 8-K 8-K 2.02,9.01 0001711279-22-000018 001-38210 22905293 34 243837 1 1
2022-05-09 10-Q 10-Q 0001711279-22-000016 001-38210 22904907 34 6267833 1 1
2022-04-07 DEFA14A DEFA14A 0001193125-22-098904 001-38210 22814096 34 129477
2022-04-07 DEF 14A DEF 14A 0001193125-22-098892 001-38210 22814019 34 565583
2022-03-28 8-K 8-K 7.01,9.01 0001193125-22-086630 001-38210 22775508 34 11058805 1 1
2022-03-22 8-K 8-K 7.01,9.01 0001711279-22-000010 001-38210 22760155 34 6238275 1 1
2022-03-15 8-K 8-K 7.01,9.01 0001193125-22-076041 001-38210 22741240 34 162176 1 1
2022-03-01 4 FORM 4 0001801385-22-000005 6943
2022-03-01 4 FORM 4 0001860010-22-000002 5776
2022-03-01 4 FORM 4 0001298711-22-000003 9411
2022-03-01 4 FORM 4 0001298709-22-000003 9406
2022-02-28 8-K 8-K 2.02,5.02,9.01 0001711279-22-000007 001-38210 22691307 34 323247 1 1
2022-02-28 10-K 10-K 0001711279-22-000004 001-38210 22683916 34 26248192 1 1
2022-02-17 S-8 FORM S-8 0001193125-22-045526 333-262825 22648990 33 91287
2022-02-14 SC 13G/A SC 13G/A 0001104659-22-023140 005-90133 22634493 34 70726
2022-02-14 SC 13G/A SCHEDULE 13G (AMENDMENT NO. 1) 0000899140-22-000342 005-90133 22633787 34 54346
2022-02-09 SC 13G/A filing.txt 0000315066-22-001049 005-90133 22604413 34 8677
2022-02-03 SC 13G/A us5011471027_020322.txt 0000834237-22-006360 005-90133 22589099 34 13393
2022-02-02 5 ANNUAL STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP 0001062993-22-002225 4632
2022-01-31 4 FORM 4 0001834528-22-000003 5294
2022-01-31 4 FORM 4 0001852880-22-000002 5216
2022-01-26 3 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES 0001062993-22-001614 5888
2022-01-18 8-K 8-K 5.02,7.01,9.01 0001193125-22-011224 001-38210 22535230 34 181086 1 1
2021-12-14 4 FORM 4 SUBMISSION 0000899243-21-048125 7557
2021-12-14 4 FORM 4 SUBMISSION 0000899243-21-048122 5871
2021-12-14 4 FORM 4 SUBMISSION 0000899243-21-048119 7530
2021-12-06 SC 13G SCHEDULE 13G 0000899140-21-000749 005-90133 211473945 34 62084
2021-12-03 8-K 8-K 1.01,9.01 0001193125-21-347836 001-38210 211470012 34 396554 1 1
2021-12-01 424B2 424B2 0001193125-21-345559 333-237983 211464022 33 783673
2021-11-29 424B5 424B5 0001193125-21-342336 333-237983 211457011 33 779893
2021-11-29 8-K 8-K 7.01,8.01,9.01 0001193125-21-342256 001-38210 211456193 34 9998029 1 1
2021-11-08 8-K 8-K 2.02,9.01 0001193125-21-323118 001-38210 211388598 34 222210 1 1
2021-11-08 10-Q 10-Q 0001711279-21-000031 001-38210 211386502 34 7354084 1 1
2021-09-16 8-K 8-K 1.01,9.01 0001193125-21-275175 001-38210 211258320 34 314615 1 1
2021-08-19 8-K/A 8-K/A 7.01 0001193125-21-251597 001-38210 211190798 34 155960 1 1
2021-08-09 8-K 8-K 2.02,7.01,9.01 0001193125-21-240419 001-38210 211156374 34 13628409 1 1
2021-08-09 10-Q 10-Q 0001711279-21-000027 001-38210 211154707 34 32172793 1 1
2021-08-02 8-K 8-K 7.01,9.01 0001193125-21-233350 001-38210 211136572 34 173905 1 1
2021-07-07 8-K 8-K 1.01 0001193125-21-209919 001-38210 211077875 34 151671 1 1
2021-07-02 4 FORM 4 0001711279-21-000022 5111
2021-07-02 4 FORM 4 0001711279-21-000020 5228
2021-07-02 4 FORM 4 0001711279-21-000018 5220
2021-07-02 4 FORM 4 0001711279-21-000016 5254
2021-07-02 4 FORM 4 0001711279-21-000014 5250
2021-07-01 8-K 8-K 7.01,9.01 0001193125-21-206566 001-38210 211067179 34 13949081 1 1
2021-06-02 4 PRIMARY DOCUMENT 0000925421-21-000140 5672
2021-05-24 8-K 8-K 5.07 0001193125-21-170838 001-38210 21954847 34 154103 1 1
2021-05-11 3 FORM 3 SUBMISSION 0000899243-21-019155 7884
2021-05-10 8-K 8-K 2.02,9.01 0001193125-21-155718 001-38210 21905341 34 217124 1 1
2021-05-10 10-Q 10-Q 0001711279-21-000012 001-38210 21905311 34 15182518 1 1
2021-04-06 DEFA14A DEFA14A 0001193125-21-107634 001-38210 21809516 34 150508
2021-04-06 DEF 14A DEF 14A 0001193125-21-107627 001-38210 21809491 34 337948
2021-03-24 8-K 8-K 7.01,9.01 0001193125-21-091865 001-38210 21766536 34 181842 1 1
2021-03-09 SC 13G/A SC 13G/A 0001104659-21-033779 005-90133 21725778 34 52483
2021-03-02 4 FORM 4 SUBMISSION 0000899243-21-009168 8870
2021-03-02 4 FORM 4 SUBMISSION 0000899243-21-009163 7104
2021-03-02 4 FORM 4 SUBMISSION 0000899243-21-009162 8847
2021-03-01 10-K 10-K 0001711279-21-000006 001-38210 21693924 34 36479925 1 1
2021-03-01 8-K 8-K 2.02,9.01 0001193125-21-062354 001-38210 21693912 34 225179 1 1
2021-02-16 SC 13G/A SCHEDULE 13G/A 0001104659-21-024094 005-90133 21639090 34 79657
2021-02-16 SC 13G/A SCHEDULE 13G/A 0001104659-21-023934 005-90133 21638242 34 70558
2021-02-16 SC 13G/A krys13gadec20.txt 0000080255-21-001287 005-90133 34 7000
2021-02-12 SC 13G/A AMENDMENT NO. 1 0000947871-21-000177 005-90133 21628927 34 66490
2021-02-08 SC 13G/A filing.txt 0000315066-21-001103 005-90133 21599691 34 8333
2021-02-05 8-K 8-K 1.01,9.01 0001193125-21-030740 001-38210 21596481 34 355311 1 1
2021-02-04 SC 13G/A SC 13G/A 0001193125-21-028887 005-90133 21591689 34 111270
2021-02-04 424B2 424B2 0001193125-21-027616 333-237983 21588162 33 689443
2021-02-02 424B5 FORM 424(B)(5) 0001193125-21-025862 333-237983 21581601 33 685540
2021-02-02 8-K 8-K 1.01,2.02,9.01 0001193125-21-025839 001-38210 21581341 34 527709 1 1
2021-02-02 SC 13G us5011471027_020221.txt 0000834237-21-006858 005-90133 21580621 34 13327
2021-01-22 S-8 FORM S-8 0001193125-21-014838 333-252351 21546464 33 65854
2021-01-07 8-K 8-K 7.01,9.01 0001193125-21-003754 001-38210 21513021 34 13837373 1 1
2021-01-05 4 FORM 4 SUBMISSION 0000899243-21-000413 5308
2021-01-05 4 FORM 4 SUBMISSION 0000899243-21-000410 5312
2021-01-05 3 FORM 3 SUBMISSION 0000899243-21-000408 6222
2021-01-05 3 FORM 3 SUBMISSION 0000899243-21-000407 6241
2021-01-04 8-K 8-K 5.02,7.01,9.01 0001193125-21-000338 001-38210 21500238 34 184763 1 1
2020-12-31 8-K 8-K 1.01,9.01 0001193125-20-330646 001-38210 201429521 34 393259 1 1
2020-12-31 424B5 FORM 424(B)(5) 0001193125-20-330622 333-237983 201429229 33 389536
2020-11-09 8-K 8-K 2.02,7.01,9.01 0001193125-20-288574 001-38210 201296256 34 25581337 1 1
2020-11-09 10-Q 10-Q 0001711279-20-000006 001-38210 201295623 34 5319865 1 1
2020-10-01 8-K 8-K 7.01,9.01 0001193125-20-261297 001-38210 201215937 34 9822071 1 1
2020-09-17 4 FORM 4 SUBMISSION 0000899243-20-025576 19277
2020-08-10 8-K 8-K 2.02,9.01 0001193125-20-214151 001-38210 201087195 34 47058
2020-08-07 10-Q 10-Q 0001564590-20-038503 001-38210 201086712 34 6660604 1
2020-08-07 4 FORM 4 SUBMISSION 0000899243-20-021815 9872
2020-08-07 4 FORM 4 SUBMISSION 0000899243-20-021813 9991
2020-08-07 4 FORM 4 SUBMISSION 0000899243-20-021806 9988
2020-06-17 4 FORM 4 SUBMISSION 0000899243-20-016834 14977
2020-06-01 8-K FORM 8-K 5.07 0001193125-20-157272 001-38210 20933625 34 21034
2020-05-21 8-K FORM 8-K 1.01,9.01 0001193125-20-148674 001-38210 20901970 34 175712
2020-05-19 424B2 424B2 0001193125-20-146248 333-237983 20894706 33 467828
2020-05-19 4 FORM 4 SUBMISSION 0001209191-20-030562 21235
2020-05-18 424B5 FORM 424B5 0001193125-20-145064 333-237983 20889931 33 462182
2020-05-14 8-K FORM 8-K 7.01,9.01 0001193125-20-142266 001-38210 20875344 34 39280
2020-05-13 8-K FORM 8-K 8.01,9.01 0001193125-20-141675 001-38210 20873754 34 763333
2020-05-08 DEFA14A DEFA14A 0001193125-20-137542 001-38210 20860533 34 34441
2020-05-05 8-K FORM 8-K 5.02 0001193125-20-133769 001-38210 20849326 34 17455
2020-05-04 S-3ASR S-3ASR 0001193125-20-131883 333-237983 20843061 33 697625
2020-05-04 8-K 8-K 2.02,9.01 0001193125-20-131774 001-38210 20842823 34 55796
2020-05-04 10-Q 10-Q 0001564590-20-020571 001-38210 20842197 34 5925119 1
2020-04-13 DEF 14A DEF 14A 0001564590-20-016447 001-38210 20789324 34 745701
2020-03-18 4 FORM 4 SUBMISSION 0001209191-20-020124 14693
2020-03-10 8-K 8-K 2.02,9.01 0001193125-20-068325 001-38210 20700432 34 58957
2020-03-10 10-K 10-K 0001564590-20-009550 001-38210 20699944 34 9094107 1
2020-02-25 4 FORM 4 SUBMISSION 0001209191-20-012615 5384
2020-02-25 3 FORM 3 SUBMISSION 0001209191-20-012604 6073
2020-02-25 8-K 8-K 5.02,9.01 0001193125-20-048452 001-38210 20651670 34 38212
2020-02-20 4 FORM 4 SUBMISSION 0001209191-20-011211 23270
2020-02-14 SC 13G orbimed-krys123119.htm 0001172661-20-000922 005-90133 20623783 34 87748
2020-02-14 SC 13G orbimed-krys123119.htm 0001172661-20-000926 005-90133 20621845 34 87748
2020-02-14 SC 13G SCHEDULE 13G 0001104659-20-021823 005-90133 20620502 34 73019
2020-02-14 SC 13G/A SC 13G/A 0001193125-20-038241 005-90133 20619961 34 42743
2020-02-14 SC 13G/A SCHEDULE 13G/A 0001104659-20-021755 005-90133 20619957 34 89047
2020-02-14 SC 13G/A SC 13G/A 0001193125-20-038236 005-90133 20619902 34 42097
2020-02-14 SC 13G krys13gdec19.txt 0000080255-20-001342 005-90133 34 6800
2020-02-13 SC 13G/A AMENDMENT NO. 2 TO SCHEDULE 13G 0001193125-20-033443 005-90133 20605713 34 106549

Latest XBRL company facts

One latest value per concept from companyfacts (309 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 29.63M 2026-10-28 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
dei EntityPublicFloat Entity Public Float USD 3.50B 2025-06-30 2025 FY 10-K 2026-02-17 0001711279-26-000016
us-gaap AccountsPayableAndOtherAccruedLiabilitiesCurrent Accounts Payable and Other Accrued Liabilities, Current USD 39.41M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 6.73M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 133.12M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap AccruedIncomeTaxes Accrued Income Taxes USD 16.87M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 3.33M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 39.07M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -9.24M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 1.25B 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap AdjustmentForAmortization Amortization USD -1.28M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-26 0001711279-24-000005
us-gaap AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation Share-based Payment Arrangement, Decrease for Tax Withholding Obligation USD 1.81M 2025-01-01 2025-03-31 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt Adjustments to Additional Paid in Capital, Equity Component of Convertible Debt USD 3.16M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-12 0001564590-18-005252
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 14.88M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 227,000 2021-12-03 2023 FY 10-K 2024-02-26 0001711279-24-000005
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 41.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap AllowanceForDoubtfulAccountsReceivable Accounts Receivable, Allowance for Credit Loss USD 98.50M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap AllowanceForDoubtfulAccountsReceivableWriteOffs Accounts Receivable, Allowance for Credit Loss, Writeoff USD 52.89M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 3.83M 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-08 0001711279-23-000029
us-gaap Assets Assets USD 1.59B 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap AssetsCurrent Assets, Current USD 1.12B 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 95,000 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 4.54M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap AvailableForSaleSecuritiesCurrent Available-for-sale Securities, Current USD 8.40M 2019-09-30 2019 Q3 10-Q 2019-11-04 0001564590-19-039515
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 449.01M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap AvailableForSaleSecuritiesGrossUnrealizedGains Available-for-sale Securities, Gross Unrealized Gain USD 14,000 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-07 0001564590-19-016236
us-gaap AvailableForSaleSecuritiesGrossUnrealizedLoss Available-for-sale Securities, Gross Unrealized Loss USD 2,000 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-06 0001564590-18-019294
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 663,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 462.84M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD 104.16M 2020-01-01 2020-06-30 2020 Q2 10-Q 2020-08-07 0001564590-20-038503
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 911.90M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 462.84M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -33.46M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 80.00M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 29.63M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 29.63M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap CommonStockValue Common Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap CommonUnitAuthorized Common Unit, Authorized shares 0 2017-12-31 2017 FY 10-K 2018-03-12 0001564590-18-005252
us-gaap CommonUnitIssuanceValue Common Unit, Issuance Value USD 0 2017-12-31 2017 FY 10-K 2018-03-12 0001564590-18-005252
us-gaap CommonUnitIssued Common Unit, Issued shares 0 2017-12-31 2017 FY 10-K 2018-03-12 0001564590-18-005252
us-gaap CommonUnitOutstanding Common Unit, Outstanding shares 0 2017-12-31 2017 FY 10-K 2018-03-12 0001564590-18-005252
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD 163.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap ConstructionInProgressExpendituresIncurredButNotYetPaid Construction in Progress Expenditures Incurred but Not yet Paid USD 582,000 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-05 0001564590-18-026663
us-gaap ConstructionInProgressGross Construction in Progress, Gross USD 10.00M 2020-10-31 2023 FY 10-K 2024-02-26 0001711279-24-000005
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 12.66M 2017-01-01 2017-09-30 2018 Q3 10-Q 2018-11-05 0001564590-18-026663
us-gaap ConvertibleLongTermNotesPayable Convertible Notes Payable, Noncurrent USD 1.15M 2016-12-31 2017 FY 10-K 2018-03-12 0001564590-18-005252
us-gaap ConvertibleNotesPayable Convertible Notes Payable USD 0 2017-12-31 2017 FY 10-K 2018-03-12 0001564590-18-005252
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 2.99M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001711279-26-000016
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD 671,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001711279-26-000016
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 11.91M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001711279-26-000016
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD 8.26M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001711279-26-000016
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 4.14M 2017-01-01 2017-09-30 2018 Q3 10-Q 2018-11-05 0001564590-18-026663
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 4.14M 2017-08-08 2018 Q3 10-Q 2018-11-05 0001564590-18-026663
us-gaap DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction USD 56,000 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-05 0001564590-18-026663
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD -19.64M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001711279-26-000016
us-gaap DeferredForeignIncomeTaxExpenseBenefit Deferred Foreign Income Tax Expense (Benefit) USD -450,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001711279-26-000016
us-gaap DeferredIncomeTaxAssetsNet Deferred Income Tax Assets, Net USD 22.82M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD -27.27M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001711279-26-000016
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD -7.19M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001711279-26-000016
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 15.95M 2025-12-31 2025 FY 10-K 2026-02-17 0001711279-26-000016
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 52.52M 2025-12-31 2025 FY 10-K 2026-02-17 0001711279-26-000016
us-gaap DeferredTaxAssetsInventory Deferred Tax Assets, Inventory USD 1.02M 2025-12-31 2025 FY 10-K 2026-02-17 0001711279-26-000016
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 22.82M 2025-12-31 2025 FY 10-K 2026-02-17 0001711279-26-000016
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 38.30M 2025-12-31 2025 FY 10-K 2026-02-17 0001711279-26-000016
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 13.24M 2025-12-31 2025 FY 10-K 2026-02-17 0001711279-26-000016
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 16,000 2025-12-31 2025 FY 10-K 2026-02-17 0001711279-26-000016
us-gaap DeferredTaxAssetsPropertyPlantAndEquipment Deferred Tax Assets, Property, Plant and Equipment USD 0 2022-12-31 2021 FY 10-K 2023-02-27 0001711279-23-000008
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 1.85M 2025-12-31 2025 FY 10-K 2026-02-17 0001711279-26-000016
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 11.43M 2025-12-31 2025 FY 10-K 2026-02-17 0001711279-26-000016
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities USD 2.42M 2025-12-31 2025 FY 10-K 2026-02-17 0001711279-26-000016
us-gaap DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross Deferred Tax Assets, Unrealized Losses on Available-for-Sale Securities, Gross USD 0 2023-12-31 2023 FY 10-K 2024-02-26 0001711279-24-000005
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 14.21M 2025-12-31 2025 FY 10-K 2026-02-17 0001711279-26-000016
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 15.48M 2025-12-31 2025 FY 10-K 2026-02-17 0001711279-26-000016
us-gaap DeferredTaxLiabilitiesInvestments Deferred Tax Liabilities, Investments USD 581,000 2025-12-31 2025 FY 10-K 2026-02-17 0001711279-26-000016
us-gaap DeferredTaxLiabilitiesPrepaidExpenses Deferred Tax Liabilities, Prepaid Expenses USD 1.39M 2025-12-31 2025 FY 10-K 2026-02-17 0001711279-26-000016
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 11.76M 2025-12-31 2025 FY 10-K 2026-02-17 0001711279-26-000016
us-gaap Depreciation Depreciation USD 4.35M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 2.57M 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-06 0001711279-23-000073
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 4.05M 2022-01-01 2022-12-31 2021 FY 10-K 2023-02-27 0001711279-23-000008
us-gaap DividendsCommonStockStock Dividends, Common Stock, Stock USD 0 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-05 0001564590-18-026663
us-gaap DividendsPreferredStock Dividends, Preferred Stock USD 0 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-12 0001564590-18-005252
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares 5.9 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.74 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-10 0001711279-21-000012
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares 5.66 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure -0.081 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001711279-26-000016
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001711279-26-000016
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.271 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001711279-26-000016
us-gaap EffectiveIncomeTaxRateReconciliationFdiiAmount EffectiveIncomeTaxRateReconciliationFdiiAmount USD 1.18M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001711279-26-000016
us-gaap EffectiveIncomeTaxRateReconciliationFdiiPercent EffectiveIncomeTaxRateReconciliationFdiiPercent pure 0.006 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001711279-26-000016
us-gaap EffectiveIncomeTaxRateReconciliationGiltiAmount EffectiveIncomeTaxRateReconciliationGiltiAmount USD 1,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001711279-26-000016
us-gaap EffectiveIncomeTaxRateReconciliationGiltiPercent EffectiveIncomeTaxRateReconciliationGiltiPercent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001711279-26-000016
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001711279-26-000016
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.014 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001711279-26-000016
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001711279-26-000016
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure -0.028 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001711279-26-000016
us-gaap EffectiveIncomeTaxRateReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Percent pure 0.028 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001711279-26-000016
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsOther Effective Income Tax Rate Reconciliation, Tax Credit, Other, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001711279-26-000016
us-gaap EffectiveIncomeTaxRateReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent pure 0.019 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001711279-26-000016
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD -4.74M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount Share-based Payment Arrangement, Amount Capitalized USD 0 2021-01-01 2021-12-31 2023 FY 10-K 2024-02-26 0001711279-24-000005
us-gaap EscrowDeposit Escrow Deposit USD 1.50M 2020-10-31 2023 FY 10-K 2024-02-26 0001711279-24-000005
us-gaap FederalIncomeTaxExpenseBenefitContinuingOperations Federal Income Tax Expense (Benefit), Continuing Operations USD -16.65M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001711279-26-000016
us-gaap FIFOInventoryAmount FIFO Inventory Amount USD 5.30M 2023-09-30 2023 Q3 10-Q 2023-11-06 0001711279-23-000073
us-gaap FinanceLeaseLiability Finance Lease, Liability USD 10.00M 2020-10-05 2022 Q3 10-Q 2022-11-07 0001711279-22-000058
us-gaap FinanceLeaseRightOfUseAssetAmortization Finance Lease, Right-of-Use Asset, Amortization USD 26,000 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-04 0001564590-20-020571
us-gaap ForeignCurrencyTransactionGainLossAfterTax ForeignCurrencyTransactionGainLossAfterTax USD 447,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-03 0001711279-25-000087
us-gaap ForeignCurrencyTransactionGainLossBeforeTax Foreign Currency Transaction Gain (Loss), before Tax USD -1.20M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001711279-26-000016
us-gaap ForeignIncomeTaxExpenseBenefitContinuingOperations Foreign Income Tax Expense (Benefit), Continuing Operations USD 221,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001711279-26-000016
us-gaap GainLossOnDispositionOfIntangibleAssets Gain (Loss) on Disposition of Intangible Assets USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001711279-26-000016
us-gaap GainLossRelatedToLitigationSettlement Gain (Loss) Related to Litigation Settlement USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001711279-26-000016
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD -3.16M 2017-08-08 2018 Q3 10-Q 2018-11-05 0001564590-18-026663
us-gaap GainsLossesOnSalesOfAssets Gain (Loss) on Disposition of Assets for Financial Service Operations USD -27,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-26 0001711279-24-000005
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 98.40M 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-26 0001711279-24-000005
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-26 0001711279-24-000005
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD 207.67M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap IncomeTaxesPaid Income Taxes Paid USD 22.72M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 14.79M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001711279-26-000016
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 33.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap IncomeTaxPaidFederalAfterRefundReceived IncomeTaxPaidFederalAfterRefundReceived USD 12.21M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001711279-26-000016
us-gaap IncomeTaxPaidForeignAfterRefundReceived IncomeTaxPaidForeignAfterRefundReceived USD 259,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001711279-26-000016
us-gaap IncomeTaxPaidStateAndLocalAfterRefundReceived IncomeTaxPaidStateAndLocalAfterRefundReceived USD 2.32M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001711279-26-000016
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD -51.23M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001711279-26-000016
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD 1.02M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-12 0001564590-18-005252
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD 6,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-19 0001711279-25-000008
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD 39.79M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001711279-26-000016
us-gaap IncomeTaxReconciliationNondeductibleExpenseOther Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount USD 81,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001711279-26-000016
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD -2.72M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001711279-26-000016
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD -45,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001711279-26-000016
us-gaap IncomeTaxReconciliationOtherReconcilingItems Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount USD -114,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-19 0001711279-25-000008
us-gaap IncomeTaxReconciliationPriorYearIncomeTaxes Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount USD -110,000 2019-01-01 2019-12-31 2019 FY 10-K 2020-03-10 0001564590-20-009550
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD -5.23M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001711279-26-000016
us-gaap IncomeTaxReconciliationTaxContingencies Effective Income Tax Rate Reconciliation, Tax Contingency, Amount USD 5.23M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001711279-26-000016
us-gaap IncomeTaxReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Amount USD 3.88M 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-19 0001711279-25-000008
us-gaap IncomeTaxReconciliationTaxCreditsOther Effective Income Tax Rate Reconciliation, Tax Credit, Other, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001711279-26-000016
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 3.60M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001711279-26-000016
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 4.29M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 6.49M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD 2.53M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap IncreaseDecreaseInDeferredIncomeTaxes Increase (Decrease) in Deferred Income Taxes USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap IncreaseDecreaseInDeferredLiabilities Increase (Decrease) in Deferred Liabilities USD 28,000 2018-01-01 2018-09-30 2019 Q3 10-Q 2019-11-04 0001564590-19-039515
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD 3.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD -11,000 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-04 0001711279-24-000056
us-gaap IncreaseDecreaseInOtherNoncurrentLiabilities Increase (Decrease) in Other Noncurrent Liabilities USD 3.26M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 5.68M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD -198,000 2017-01-01 2017-09-30 2017 Q3 10-Q 2017-11-13 0001193125-17-341032
us-gaap IncreaseDecreaseInPrepaidRent Increase (Decrease) in Prepaid Rent USD 0 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-08 0001711279-21-000031
us-gaap IncreaseDecreaseInPrepaidTaxes Increase (Decrease) in Prepaid Taxes USD -5.47M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap IncrementalCommonSharesAttributableToShareBasedPaymentArrangements Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements shares 1.20M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap InterestExpense Interest Expense USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-26 0001711279-24-000005
us-gaap InterestIncomeExpenseNonoperatingNet Interest Income (Expense), Nonoperating, Net USD 24.41M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap InterestPayableCurrentAndNoncurrent Interest Payable USD 112,000 2017-08-08 2018 Q3 10-Q 2018-11-05 0001564590-18-026663
us-gaap InventoryAdjustments Inventory Adjustments USD 0 2023-12-31 2023 FY 10-K 2024-02-26 0001711279-24-000005
us-gaap InventoryFinishedGoodsNetOfReserves Inventory, Finished Goods, Net of Reserves USD 10.95M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap InventoryNet Inventory, Net USD 50.79M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap InventoryRawMaterialsNetOfReserves Inventory, Raw Materials, Net of Reserves USD 17.79M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap InventoryWorkInProcessNetOfReserves Inventory, Work in Process, Net of Reserves USD 22.05M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 178,000 2020-01-01 2020-03-31 2020 Q1 10-Q 2020-05-04 0001564590-20-020571
us-gaap LeaseCost Lease, Cost USD 1.38M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 15.63M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 7.28M 2025-12-31 2025 FY 10-K 2026-02-17 0001711279-26-000016
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 1.92M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 2.02M 2025-12-31 2025 FY 10-K 2026-02-17 0001711279-26-000016
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 2.02M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 1.99M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 1.95M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 472,000 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 7.04M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap Liabilities Liabilities USD 150.47M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 1.59B 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap LiabilitiesCurrent Liabilities, Current USD 142.14M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap LimitedLiabilityCompanyLLCPreferredUnitAuthorized Limited Liability Company (LLC) Preferred Unit, Authorized shares 0 2017-12-31 2017 FY 10-K 2018-03-12 0001564590-18-005252
us-gaap LimitedLiabilityCompanyLLCPreferredUnitIssuanceValue Limited Liability Company (LLC) Preferred Unit, Issuance Value USD 0 2017-12-31 2017 FY 10-K 2018-03-12 0001564590-18-005252
us-gaap LimitedLiabilityCompanyLLCPreferredUnitIssued Limited Liability Company (LLC) Preferred Unit, Issued shares 0 2017-12-31 2017 FY 10-K 2018-03-12 0001564590-18-005252
us-gaap LimitedLiabilityCompanyLLCPreferredUnitOutstanding Limited Liability Company (LLC) Preferred Unit, Outstanding shares 0 2017-12-31 2017 FY 10-K 2018-03-12 0001564590-18-005252
us-gaap LitigationReserveCurrent Estimated Litigation Liability, Current USD 0 2025-12-31 2025 FY 10-K 2026-02-17 0001711279-26-000016
us-gaap LitigationSettlementExpense Litigation Settlement, Expense USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001711279-26-000016
us-gaap LongTermDebt Long-term Debt USD 4.25M 2017-08-08 2018 Q3 10-Q 2018-11-05 0001564590-18-026663
us-gaap LongTermInvestments Long-term Investments USD 282.30M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap LossContingencyRelatedReceivableCarryingValueAdditions Loss Contingency, Receivable, Additions USD 560,000 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-28 0001711279-22-000004
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 8.01M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 6,000 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-07 0001564590-18-011136
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -283.15M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -7,000 2017-01-01 2017-03-31 2018 Q1 10-Q 2018-05-07 0001564590-18-011136
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD 246.42M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -2.37M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-07 0001564590-18-011136
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD 173.77M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -7.18M 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-05 0001564590-18-026663
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 1.13M 2019-01-01 2019-06-30 2019 Q2 10-Q 2019-08-05 0001564590-19-028548
us-gaap NotesPayableRelatedPartiesNoncurrent Notes Payable, Related Parties, Noncurrent USD 0 2017-12-31 2017 FY 10-K 2018-03-12 0001564590-18-005252
us-gaap NumberOfOperatingSegments Number of Operating Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap NumberOfReportableSegments Number of Reportable Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap OperatingExpenses Operating Expenses USD 179.67M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap OperatingIncomeLoss Operating Income (Loss) USD 183.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap OperatingLeaseCost Operating Lease, Cost USD 1.14M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 1.30M 2021-01-01 2021-12-31 2021 FY 10-K 2022-02-28 0001711279-22-000004
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 8.59M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 1.82M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 6.77M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 6.61M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 630,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 1.91M 2018-06-30 2018 Q2 10-Q 2018-08-06 0001564590-18-019294
us-gaap OperatingLeasesFutureMinimumPaymentsDueFutureMinimumSubleaseRentals Operating Leases, Future Minimum Payments Due, Future Minimum Sublease Rentals USD 18,000 2017-12-31 2017 FY 10-K 2018-03-12 0001564590-18-005252
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 261,000 2018-06-30 2018 Q2 10-Q 2018-08-06 0001564590-18-019294
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 256,000 2018-06-30 2018 Q2 10-Q 2018-08-06 0001564590-18-019294
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 251,000 2018-06-30 2018 Q2 10-Q 2018-08-06 0001564590-18-019294
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 225,000 2018-06-30 2018 Q2 10-Q 2018-08-06 0001564590-18-019294
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 862,000 2018-06-30 2018 Q2 10-Q 2018-08-06 0001564590-18-019294
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 55,000 2018-06-30 2018 Q2 10-Q 2018-08-06 0001564590-18-019294
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.097 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 92,000 2018-09-30 2018 Q3 10-Q 2018-11-05 0001564590-18-026663
us-gaap OtherAssetsCurrent Other Assets, Current USD 19,000 2017-12-31 2017 FY 10-K 2018-03-12 0001564590-18-005252
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 269,000 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent USD -4.75M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax USD -714,000 2025-07-01 2025-09-30 2025 Q3 10-Q 2025-11-03 0001711279-25-000087
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -5.63M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 4.33M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 1.56M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap OtherNoncashExpense Other Noncash Expense USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-26 0001711279-24-000005
us-gaap OtherOperatingActivitiesCashFlowStatement Other Operating Activities, Cash Flow Statement USD -180,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap PaidInKindInterest Paid-in-Kind Interest USD 3.26M 2017-01-01 2017-09-30 2018 Q3 10-Q 2018-11-05 0001564590-18-026663
us-gaap PaymentsRelatedToTaxWithholdingForShareBasedCompensation Payment, Tax Withholding, Share-based Payment Arrangement USD 749,000 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-26 0001711279-24-000005
us-gaap PaymentsToAcquireAvailableForSaleSecurities Payments to Acquire Available-for-sale Securities USD 5.63M 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-05 0001564590-18-026663
us-gaap PaymentsToAcquireAvailableForSaleSecuritiesDebt Payments to Acquire Debt Securities, Available-for-sale USD 422.54M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001711279-26-000016
us-gaap PaymentsToAcquireInvestments Payments to Acquire Investments USD 612.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap PaymentsToAcquireLongtermInvestments Payments to Acquire Long-term Investments USD 21.46M 2021-01-01 2021-06-30 2021 Q2 10-Q 2021-08-09 0001711279-21-000027
us-gaap PaymentsToAcquireOtherProductiveAssets Payments to Acquire Other Productive Assets USD 263,000 2019-01-01 2019-03-31 2020 Q1 10-Q 2020-05-04 0001564590-20-020571
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 11.71M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap PreferredStockLiquidationPreferenceValue Preferred Stock, Liquidation Preference, Value USD 1.41M 2016-12-31 2017 FY 10-K 2018-03-12 0001564590-18-005252
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2022-09-30 2022 Q3 10-Q 2022-11-07 0001711279-22-000058
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 20.00M 2022-09-30 2022 Q3 10-Q 2022-11-07 0001711279-22-000058
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 2.06M 2022-09-30 2022 Q3 10-Q 2022-11-07 0001711279-22-000058
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2022-09-30 2022 Q3 10-Q 2022-11-07 0001711279-22-000058
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2022-09-30 2022 Q3 10-Q 2022-11-07 0001711279-22-000058
us-gaap PreferredUnitsAuthorized Preferred Units, Authorized shares 100 2016-04-15 2017 FY 10-K 2018-03-12 0001564590-18-005252
us-gaap PreferredUnitsIssued Preferred Units, Issued shares 96,345 2017-12-31 2017 FY 10-K 2018-03-12 0001564590-18-005252
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 17.47M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 304,000 2017-12-31 2017 FY 10-K 2018-03-12 0001564590-18-005252
us-gaap PrepaidExpenseCurrentAndNoncurrent Prepaid Expense USD 112,000 2023-06-30 2023 Q1 10-Q 2023-08-07 0001711279-23-000064
us-gaap PrepaidRent Prepaid Rent USD 2.40M 2020-09-30 2020 Q3 10-Q 2020-11-09 0001711279-20-000006
us-gaap PrepaidTaxes Prepaid Taxes USD 8.54M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 1.30M 2017-01-01 2017-09-30 2018 Q3 10-Q 2018-11-05 0001564590-18-026663
us-gaap ProceedsFromInsuranceSettlementOperatingActivities Proceeds from Insurance Settlement, Operating Activities USD 3.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001711279-26-000016
us-gaap ProceedsFromIssuanceOfPreferredLimitedPartnersUnits Proceeds from Issuance of Preferred Limited Partners Units USD 754,000 2017-12-01 2017-12-31 2017 FY 10-K 2018-03-12 0001564590-18-005252
us-gaap ProceedsFromIssuanceOfPreferredStockAndPreferenceStock Proceeds from Issuance of Preferred Stock and Preference Stock USD 7.00M 2017-01-01 2017-09-30 2018 Q3 10-Q 2018-11-05 0001564590-18-026663
us-gaap ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale USD 289.88M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-03 0001711279-25-000087
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 1.00M 2017-01-01 2017-09-30 2018 Q3 10-Q 2018-11-05 0001564590-18-026663
us-gaap ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments Proceeds from Sale, Maturity and Collection of Short-term Investments USD 340.65M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap ProceedsFromSaleOfIntangibleAssets Proceeds from Sale of Intangible Assets USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001711279-26-000016
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 25.09M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 191.36M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 152.29M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap ProvisionForDoubtfulAccounts Accounts Receivable, Credit Loss Expense (Reversal) USD 83.27M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap RealizedInvestmentGainsLosses Realized Investment Gains (Losses) USD 1.75M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 44.74M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD 197.93M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 362.92M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap SaleOfStockConsiderationReceivedOnTransaction Sale of Stock, Consideration Received on Transaction USD 160.00M 2023-05-22 2023-05-23 2024 Q2 10-Q 2024-08-05 0001711279-24-000040
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 114.61M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 41.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant shares 1.69M 2020-12-31 2020 FY 10-K 2021-03-01 0001711279-21-000006
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 302.98M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 1.22M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 84.04 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value USD 71.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-26 0001711279-24-000005
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 84,713 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 163.54 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 390,042 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 389.43M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 2.00M 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 138.23 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 3.69M 2019-09-30 2019 Q3 10-Q 2019-11-04 0001564590-19-039515
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares shares 133,690 2019-01-01 2019-09-30 2019 Q3 10-Q 2019-11-04 0001564590-19-039515
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 74.43 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-26 0001711279-24-000005
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 290.49 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap SharesPaidForTaxWithholdingForShareBasedCompensation Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation shares 7,500 2022-04-01 2022-06-30 2022 Q3 10-Q 2022-11-07 0001711279-22-000058
us-gaap StateAndLocalIncomeTaxExpenseBenefitContinuingOperations State and Local Income Tax Expense (Benefit), Continuing Operations USD 1.07M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001711279-26-000016
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 1.44B 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.222 2017-09-04 2017-09-05 2018 Q3 10-Q 2018-11-05 0001564590-18-026663
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 337,039 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 12.66M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-12 0001564590-18-005252
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 32.40M 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-17 0001711279-26-000016
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures USD -11,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 3.42M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 0 2018-09-30 2018 Q3 10-Q 2018-11-05 0001564590-18-026663
us-gaap TemporaryEquityParOrStatedValuePerShare Temporary Equity, Par or Stated Value Per Share USD/shares 0 2018-09-30 2018 Q3 10-Q 2018-11-05 0001564590-18-026663
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 20.00M 2018-09-30 2018 Q3 10-Q 2018-11-05 0001564590-18-026663
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 2.06M 2018-09-30 2018 Q3 10-Q 2018-11-05 0001564590-18-026663
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 0 2018-09-30 2018 Q3 10-Q 2018-11-05 0001564590-18-026663
us-gaap TranslationAdjustmentFunctionalToReportingCurrencyIncreaseDecreaseGrossOfTax Translation Adjustment Functional to Reporting Currency, Increase (Decrease), Gross of Tax USD 236,000 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-06 0001711279-25-000044
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 10.05M 2025-12-31 2025 FY 10-K 2026-02-17 0001711279-26-000016
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001711279-26-000016
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 800,000 2025-12-31 2025 FY 10-K 2026-02-17 0001711279-26-000016
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-02-26 0001711279-24-000005
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 5.86M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001711279-26-000016
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions USD 34,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001711279-26-000016
us-gaap UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations Unrecognized Tax Benefits, Reduction Resulting from Lapse of Applicable Statute of Limitations USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-17 0001711279-26-000016
us-gaap UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate Unrecognized Tax Benefits that Would Impact Effective Tax Rate USD 8.00M 2025-12-31 2025 FY 10-K 2026-02-17 0001711279-26-000016
us-gaap UnusualOrInfrequentItemInsuranceProceeds Unusual or Infrequent Item, or Both, Insurance Proceeds USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-19 0001711279-25-000008
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 48.40M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap VariableLeaseCost Variable Lease, Cost USD 241,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 30.68M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 21.25M 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-10 0001711279-21-000012
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 29.48M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-02 0001711279-26-000071

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →